Rabinowich H - Search Results

1

Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.

Rabinowich H, Herberman RB, Whiteside TL. Rabinowich H, et al. Cell Immunol. 1993 Dec;152(2):481-98. doi: 10.1006/cimm.1993.1306. Cell Immunol. 1993. PMID: 7903063

2

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL. Rabinowich H, et al. J Immunol. 1992 Jul 1;149(1):340-9. J Immunol. 1992. PMID: 1535088

3

Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.

Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL. Rabinowich H, et al. Cell Immunol. 1991 Jul;135(2):454-70. doi: 10.1016/0008-8749(91)90290-r. Cell Immunol. 1991. PMID: 1709827

4

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.

Sedlmayr P, Rabinowich H, Winkelstein A, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: rabinowich h. Br J Cancer. 1992 Feb;65(2):222-8. doi: 10.1038/bjc.1992.45. Br J Cancer. 1992. PMID: 1739621 Free PMC article.

5

Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.

Sedlmayr P, Rabinowich H, Elder EM, Ernstoff MS, Kirkwood JM, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: rabinowich h. J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005. J Immunother (1991). 1991. PMID: 1790141

6

Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2.

Sacchi M, Vitolo D, Sedlmayr P, Rabinowich H, Johnson JT, Herberman RB, Whiteside TL. Sacchi M, et al. Among authors: rabinowich h. Int J Cancer. 1991 Mar 12;47(5):784-91. doi: 10.1002/ijc.2910470527. Int J Cancer. 1991. PMID: 2004859

7

Life in the allogeneic environment after lung transplantation.

Paradis I, Rabinowich H, Zeevi A, Yousem S, Noyes B, Hoffman R, Griffith B, Dauber J. Paradis I, et al. Among authors: rabinowich h. Lung. 1990;168 Suppl:1172-81. doi: 10.1007/BF02718259. Lung. 1990. PMID: 2117119

8

HLA-class II antigen expression in human heart-lung allografts.

Yousem SA, Curley JM, Dauber J, Paradis I, Rabinowich H, Zeevi A, Duquesnoy R, Dowling R, Zenati M, Hardesty R, et al. Yousem SA, et al. Among authors: rabinowich h. Transplantation. 1990 May;49(5):991-5. doi: 10.1097/00007890-199005000-00030. Transplantation. 1990. PMID: 2186527

9

Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection.

Dal Col RH, Zeevi A, Rabinowich H, Herlan DB, Yousem SA, Griffith BP. Dal Col RH, et al. Among authors: rabinowich h. Ann Thorac Surg. 1990 May;49(5):754-8. doi: 10.1016/0003-4975(90)90015-x. Ann Thorac Surg. 1990. PMID: 2339932

10

Clonal analysis of human tumor infiltrating lymphocytes reactive with autologous tumor cells: different target cell specificities of NK-like and cytotoxic T-cell clones.

Rabinowich H, Steiner Z, Klajman A. Rabinowich H, et al. Cell Immunol. 1987 Feb;104(2):210-7. doi: 10.1016/0008-8749(87)90023-2. Cell Immunol. 1987. PMID: 3102075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results